After many long weeks, finally an update. The results of the tests: the cancerous cells are in the bone marrow, the...

Understanding Your Test Results and Treatment Plan

I'm glad you finally have clarity on your diagnosis. Let me help you understand what these findings mean and what to expect with your upcoming treatment.

What Your Test Results Tell Us

Bone marrow involvement means the cancer cells have spread into the tissue inside your bones where blood cells are made. Lymph node involvement in the back (likely your retroperitoneal nodes) shows cancer in the lymphatic system. Oral involvement (lining of the mouth) indicates the cancer has affected mucosal tissue.

Together, these findings suggest you have systemic lymphoma — meaning it's present in multiple body locations. This is important information that helps your oncology team determine your disease stage and treatment approach.

About Your Treatment: Rituximab + Bendamustine

This is a well-established combination for certain lymphoma types. Let me explain how each drug works:

Rituximab (R) is a monoclonal antibody — think of it as a targeted immune weapon. It attaches to a protein called CD20 found on B-cell lymphoma cells, marking them for destruction by your immune system. It's been used in lymphoma treatment for over 20 years.

Bendamustine is a chemotherapy drug that damages cancer cell DNA, preventing them from dividing and growing.

According to NCCN Guidelines for Marginal Zone Lymphomas, the combination of bendamustine with rituximab is listed as a preferred first-line therapy option for certain lymphoma subtypes. This means your care team is using an evidence-based, standard approach.

What to Expect During Treatment

Your treatment will likely involve:

• Multiple cycles of the drug combination (typically given intravenously)
• Regular monitoring with blood tests and imaging scans between cycles
• Side effect management — your team will help you handle any reactions

Important Questions to Ask Your Oncology Team

Since you're starting treatment soon, here are specific questions that will help you prepare:

1. How many cycles of R-bendamustine will I receive, and how long is the entire treatment plan?
2. What are the most common side effects I should expect, and how are they managed?
3. Will I need imaging scans (PET/CT) during or after treatment to check response?
4. What should I watch for that would require me to call you immediately?
5. Are there any clinical trials I should know about, especially if my cancer doesn't respond as expected?
6. How will you monitor my bone marrow recovery during treatment?

About Your Bone Marrow

Since your cancer involves bone marrow, your care team will be particularly attentive to:

• Your blood cell counts (white blood cells, red blood cells, platelets)
• How well your bone marrow recovers between treatment cycles
• Signs of infection (since chemotherapy can lower infection-fighting white blood cells)

According to NCCN Guidelines, after treatment, you'll have imaging and lab tests to see if the cancer has responded. A complete response means no cancer remains; a partial response means some cancer is still present. Your doctor will use these results to decide next steps.

Managing Side Effects

The NCCN Guidelines emphasize asking about:

• Which side effects are most likely for YOU specifically
• How long they typically last
• What medicines can help prevent or relieve them
• When to call your care team vs. go to the ER
• What you can do to help manage pain and other side effects

A Note on Your Experience

It's completely understandable to feel relief at finally having answers after weeks of testing, even though the news is serious. Many patients find that having a clear diagnosis and treatment plan — rather than uncertainty — helps them move forward mentally and emotionally.

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

Sources: NCCN Guidelines for Patients: Marginal Zone Lymphomas (2024)